KKR is to borrow around US$1 billion to support its leveraged buyout of Taipei-listed specialty chemicals producer LCY Chemical, braving a challenging regulatory environment that has curbed private equity dealmaking to date.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
